In normal mice neonatal injection of staphylococcal enterotoxin B (SEB) induces tolerance in T cells that express reactive T cell receptor (TCK) V/~ regions. To determine if a T cell neonatal defect was present in MRL-Ipr/Ipr mice, 20 #g of SEB was injected intraperitoneally every other day into VBS.2 TCR transgenic and nontransgenic MR.b +/+ and MKL-Ipr/Ipr mice from birth to 2 wk of age. At 2 wk of age, V~8 + T cells were depleted, and SEB reactivity was lost, in spleen, lymph node, and thymus. These effects were equivalent in +/+ and Ipr/lpr SEB-tolerized mice. However, MILL-Ipr/Ipr mice failed to maintain neonatal tolerance. By 4 wk of age, there was a dramatic increase in T cells expressing V~8.2 in the peripheral lymph nodes of MRblpr/lt,r mice but not MRD +/+ mice. In vitro stimulation with SEB or TCR crosslinking revealed a total loss of neonatal tolerance 2 wk after cessation of SEB treatment in Ipr/Ipr mice, but not +/+ mice. The time-course of recovery of V~8 + T cells and reactivity to SEB and TCR crosslinking in the thymus of MRL-Ipr/Ipr mice was similar to that in the lymph node. Thymectomy at 2 wk of age eliminated tolerance loss in lymph nodes of MtLL-Ipr/Ipr mice at 4 wk of age, indicating that loss of peripheral tolerance was due to the emigration of untolerized T cells from the thymus. Challenge of neonatally tolerized MRb.lpr/Ipr mice with SEB (100 #g, i.p.) at 8 wk of age resulted in a dramatic onset of T cell-mediated autoimmune disease characterized by 30% weight loss and 60% morality. This indicated that loss of tolerance to SEB also occurred in vivo. In contrast, neonatally tolerized MRL-+ / + mice remained totally unresponsive to SEB challenge and did not undergo any detectable weight loss. These results suggest that there is normal induction of neonatal tolerance to SEB in lpr/Ipr mice, but that tolerance is not maintained after the tolerizing antigen is removed. This loss of neonatal tolerance can lead to severe weight loss and death on exposure to the tolerizing antigen later in life.
I
n MRblpr/Ipr mice, which develop lymphadenopathy and autoimmune disease, extensive studies suggest that abnormal thymic development results in release of increased numbers of T cells from the thymus before tolerance induction, leading to excessive numbers of self-reactive T cells in peripheral lymphoid organs (1) . This is supported by the recent finding that the Ipr gene is a mutation in the Fas antigen, which normally induces apoptosis (2--4) . Although autoreactive T cells are thought to play a prominent role in the development of autoimmune disease, it is unclear if the persistence of autoreactive T cells results from a defect in induction of functional elimination either by clonal deletion or anergy induction, or from a defect in the maintenance of anergy. The present experiments were designed to study directly defects in induction and maintenance of T cell tolerance in MRL-lpr/Ipr mice.
To better understand the mechanism of T cell tolerance loss in autoimmune MRL-Ipr/lpr mice, Vf18.2 TCR transgenic and nontransgenic MRl..Ipr/Ipr and MRI.. + / + mice were analyzed during and after neonatal tolerance induction by staphylococcal enterotoxin B (SEB). 1 We have previously shown that TCK transgenic lpr/Ipr mice do not produce CD4-CD8-B220 + T cells and do not develop lymphadenopathy (5) . Nevertheless, these mice develop many of the autoimmune features typical of lff'/Ipr mice (5, 6) . Thus, analysis of these TCK transgenic mice allows the analysis of autoimmunity in Ipr/Ipr mice that have phenotypically normal T cells in the absence of the potential effects of the CD4-CD8-T cell population. In addition, all the T cells 1 Abbreviation used in this paper: SEB, staphylococcal enterotoxin 13. in V~38.2 TCR transgenic mice express the VB8.2 gene and therefore are potentially reactive with SEB. Consequently, phenotypic and functional analyses are simplified. Finally, neonatal SEB injection deletes almost all V138 + T cells in nontransgenic normal mice, making it difiicult to analyze the SEB responsiveness of the few remaining V138 + T cells (7) . Although neonatal injection of SEB into V~/8.2 TCR transgenic mice also deletes large numbers of V{38.2 T cells, suf~cient numbers persist to allow analysis of the comparative roles of clonal deletion and anergy induction in neonatal tolerance.
Materials and Methods

Transgenlc Mice. Mice expressing the single B TCR transgene
derived from the Db/HY-specific B6.2.16 clone were constructed as previously described (8) .
Normal Mice. The original breeding pairs of MtLL-Ipr/lpr and MRD + / + mice were obtained from the The Jackson Laboratory (Bar Harbor, ME). The TCR V138.2 transgenic mice were backcrossed with MRL-Ipr/lpr and MILL-+ / + mice, and the transgene was identified by probing Southern blots of tail DNA as previously described (5) . Transgenic mice backcrossed with MtLblpr/lpr mice were unambiguously identified as Ipr/Ipr or Ipr/+ by observation of the transgenic-negative offspring of the third backcross for development of lymphadenopathy and autoimmunity (5) . The transgenic mice were backcrossed for at least 10 generations with MRDlpr/lpr or MILL-+ / + mice (>99% MILL) and will be referred to as TCIL-/3 transgenic MRDlpr/Ipr or TCR-B transgenic MRD +/+ mice. All mice were homozygous for H-2 k.
Antibodies and Reagents. Anti-CD4 (clone GK1.5), anti-CD8
(clone 53-6.77), anti-CD3 (clone 145-2Cll), and a pan-TCR antibody (clone H57-597) were purchased from PharMingen (San Diego, CA). Anti-V~8 (clone KJ16.133) was obtained from J. Kappler (National Jewish Hospital, Denver, CO). Highly purified SEB was purchased from Toxin Technologies (Sarasota, FL).
SEB Tolerization and Challenge. Neonatal tolerance to SEB was induced by injection of SEB intraperitoneally (20/~g/50/~1 PBS) every other day from the day of birth to 2 wk of age as previously described (7) . Challenge with SEB in vivo was carried out in SEB neonatally tolerized V/38 TCR transgenic + / + and Ipr/Ipr mice by injection with SEB intraperitoneally (100 #g/200 ~1 PBS) at 8 wk of age.
Flow Cytometry Analysis. Single cell suspensions oflymphocytes or thymocytes (106Aample) were stained with optimal concentrations of antibodies in PBS with 5% FCS and 0.1% sodium azide for 30 rain at 4~ The first-step reagent was biotin-conjugated anti-CD4. Second-step reagents were a PE-conjugated anti-CD8, a FITC-conjugated anti-pan-TCK, a FITC-conjugated anti-V~8-TCR (KJ16.133), or a FITC-conjugated anti-CD3 and a Texas red| tandem fluorochrome conjugated to streptavidin (Southern Biotechnology Associates, Birmingham, AL). Viable cells (10,000/ sample) were analyzed by flow cytometry on a FACScan | (Becton Dickinson & Co., Mountain View, CA) with logarithmic scales.
Purification of T Cell Subpopulations.
All cell separations were performed by negative selection techniques to avoid T cell activation. Single cell suspensions were prepared from axillary and inguinal lymph nodes, spleen, and thymus. Spleen or lymph node cells (10 s) were depleted of B cells and Iak-positive accessory cells using a magnetic activated cell sorter (MACS) (Miltenyi Biotec GmbH, Sunnyvale, CA) column. Purified T cells were analyzed by flow cytometry and verified to be ;>98% CD3 + . For some experiments, MHC class II-positive APC were purified from syngeneic spleen cells by depletion of T cells using anti-Thy-l.2 biotin as the initial antibodies in the column purification procedure.
Stimulation by Crosslinking of TCR or CD3. Serial dilutions from 0.5 #g/ml of either anti-V~8 TCR (clone KJ16.133) or anti-CD3 (clone 145.2Cll) mAbs were coated on flat-bottomed %-well plates (Costar, Cambridge, MA) by incubation for 12 h at 4~ The plates were thoroughly washed using sterile PBS, and purified T cells were added in duplicate cultures for 72 h. During the last 8 h of culture, 1/~Ci [3H]thymidine (Amersham Corp., Arlington Heights, IL) was added and the amount incorporated measured using a liquid scintillation counter (Beckman Instruments, Inc., Fullerton, CA).
SEB Reactivity. MHC class II-positive APC were obtained from syngeneic spleen cells that had been irradiated (3,300 tad) and T cell depleted by a MACS column as described above. In stimulation assays, T cells were purified from the lymph nodes and spleens of different strains of mice and incubated with class II APC with varying concentrations of SEB for 72 h. Proliferation was determined by pulsing the wells with 1/~Ci [3H]thymidine (Amersham Corp.) 8 h before harvest.
Assay oflL2 and IFN-y. The production of IL-2 was assayed by Ib2-dependent proliferation of HT-2 cells. Briefly, supernates were harvested from antibody-crosslinked or SEB-stimulated T cell cultures at 36 h and were kept frozen at -70~ until use. 11,-2 content was determined by [~H]thymidine (Amersham Corp.) incorporation of 5 x 103 HT-2 cells during the last 12 h of a 24-h culture with the supernates. IFN-'y production was measured by ELISA. Duplicate samples were assayed in three separate experiments, and the mean was determined. The statistical significance was determined using the W'rlcoxon signed-rank nonparametric test. (Fig. 1 A) , whereas purified lymph node T calls from SEB-untolerized control VB8 TCR transgenic + / + and [pr/Ipr mice were able to proliferate. At 4 wk of age, 2 wk after SEB tolerance induction, purified T ceils from lymph node or spleen of V/~8 TCR transgenic MILblpr/lpr mice were able to proliferate in a dose-dependent fashion to SEB (Fig. 1 B) . In contrast, purified T ceils from SEB-tolerized V~8 TCK transgenic MR.b + / + mice continued to be unresponsive. The time course of SEB anergy loss was determined using lymph node T calls from SEB-tolerized TCR V/38 transgenic MRD + / § and MILL-lpr/lpr mice (Fig. 1   C) . During, and up to 1 wk after, neonatal tolerization, there was a significantly reduced proliferative response to SEB (10 /~g/ml) by lymph node T cells from both Ipr/Ipr and + / + mice. However, at 2 and 3 wk after SEB tolerance induction, there was a rapid loss of unresponsiveness leading to hyperresponsiveness to SEB by lymph node T cells from TCR VB8 mice was assayed by the production of I1,2 and IFN-3' in response to TCR or CD3 signaling induced by different concentrations of plate-bound anti-V38 (KJ16) or anti-CD3 (145.2Cll). After TCR V38 crosslinking, there was no difference in the production of II-2 by T cells from 4-wk-old SEB tolerized nontransgenic MRGIpr/Ipr mice compared to untolerized nontransgenic MR1,1pr/livr mice ( Fig. 2 A) . In contrast, I1-2 production was markedly reduced after TCR crosslinking of T cells from lymph nodes of SEB tolerized nontransgenic MILL-+ / + mice compared with untolerized nontransgenic MILL-+ / + mice. There was a linear relationship between the production of I1-2 by lymph node T cells and the concentration of crosslinking antibody. The degree of tolerance could be quantitated by determining the slope of a least-squares linear fit of I1-2 production by T cells from tolerized mice compared with untolerized mice (Fig. 2 B) . This analysis indicated that at 4 wk of age, there was equivalent I1-2 production by T cells from lymph nodes of toler- (Fig. 2 D) .
Results
Increased Reactivity to SEB in
Since it was possible that the T cells could be anergic to TCR crosslinking but responsive to CD3 crosslinking, the experiments were also carried out in V/~8 TCR transgenic mice. In V/~8 TCR transgenic MRL-4-/ 4-mice, nearly all of the CD3 + T cells also express the V38 TCR.. There was a significant decrease in slope of the tolerized vs. untolerized IL-2 production curve by lymph node T cells from V38 TCR transgenic MILL-4. (Table 1) . Supernates from all assays were also analyzed for IFN-% and results were in agreement to those found for I1,2 production (Table 1) . These results indicate that loss of tolerance in T cells of livr mice includes both TCR and CD3 signaling, and results in increased production of both IL-2 and IFN-q/.
Neonatal Tolerance to SEB Is Associated with Development of TCR V~8duttCD4 dutt Cells in Lymph Nodes of TCR Vfl8
Transgenic MRL 4-/ 4-and MRl_,lpr/Ipr Mice. In 2-wk-old untolerized TCR V38 transgenic MR1, 4-/ 4-mice, "~80% of lymph node cells expressed high levels of TCR V38 (Fig.  3 A) . These T cells also expressed high levels of TCR ot/B and high levels of CD3, and were CD4 + (57%) or CD8 + (23%) (Fig. 3 B) . There was no significant difference between 2-wk-old untolerized TCR V38 transgenic MR1,1pr/Ipr mice and untolerized TCR V38 transgenic MRL-+ / + mice (Fig.  3, A and B) . In contrast, in 2-wk-old SEB-tolerized MR1, + / + mice, only 30% of lymph node T cells expressed high levels of TCR VB8 (Fig. 3 C) . This decrease in expression of the Vfl8 TCR was preferential, as 60% of peripheral lymph node T cells expressed high levels of TCR od3 and CD3.
The TCR V/~8b~ig ht T cells were either CD4 + or CD8 + (Fig. 3 D) . A distinct subpopulation of TCR VB8 aun T cells also expressed low levels of CD4 and CD8 (Fig. 3 D) . There was no significant difference between 2-wk-old SEB-tolerized TCR V38 transgenic MLR-+ / 4-mice and 2-wk-old SEBtolerized TCR V38 transgenic MRL-Zpr/Iivr mice. of SEB Tolerization in MRI.Apr/Ipr Mice. In 4-wk-old mice, 2 wk after SEB tolerization had been completed, there continued to be nearly equal numbers of V/~8 TCR d~n and VB8 TCR baght T cells in V/~8 TCR transgenic MR/., + / + mice ( Fig. 4 and Table 2 ). The TCR du" lymph node T cells were predominantly CD4d"nCDSaun (Fig. 4 A) , whereas the TCtLb~s h~ lymph node T cells were predominantly either CD4 + or CD8 + (Fig. 4 B) . The TCR VB8 d"u T cells exhibited a low forward light scatter intensity, suggesting they were small, resting T cells (Fig. 4C) . In contrast, 2 wk after
Increase in V~8 + T Cells in Lymph Nodes after Cessation
there was a large increase of TCK VBSb'ig ht T cells in the lymph node (Fig. 4) . These T cells were either CD4 + or CD8 + (Fig. 4 B) , and most exhibited a high forward light scatter, suggesting that these cells were activated. There was also a small population of TCR au" lymph node T cells that exhibited low forward light scatter consistent with small resting T cells (Fig. 4 C) . T cells isolated from the LN of SEB-tolerized or untolerized mice were stimulated by plate-bound anti-TCR (KJ16) or anti-CD3 as in Fig. 2 , or SEB as in Fig. 1 . The production of IL-2 and IFN-'y was assayed, and a least squares linear fit of the results from tolerized and untolerized mice carried out, as described in Fig. 2 . The ratio of the production rate in the tolerized compared with the untolerized mice is presented with the r value in parenthesis. A slope value of 1 indicates that the responses from tolerized mice have a dose-response similar to untolerized mice (i.e., failure to induce or maintain tolerance). 
Reduction of Total Lymphocyte
CD4-+ CD4-+
Light Scatter--. Light Scatter-+ Table 2) . Loss of SEB-induced neonatal tolerance occurs between 1 and 2 wk after neonatal tolerance induction in both the thymus and lymph node. Peripheral tolerance loss could be due to either production of new untolerized thymocytes or due to spontaneous loss of anergy by lymph node T cells, or a combined loss of anergy in the thymus and lymph node. To distinguish among these possibilities, SEB neonatal tolerized V/~8 TCR transgenic MILL-+ / + and MRL-lpr/lpr mice were either thymectomized or sham thymectomized at 2 wk of age, just after induction of tolerance. The reactivity of lymph node T cells to SEB was then analyzed at 4 wk of age. As expected, lymph node T cells from SEB-tolerized sham-thymectomized, VB8 TCK transgenic MR3:Ipr/Ipr mice were highly responsive to SEB, whereas SEB tolerized shamthymectomized MILL-+ / + mice remained tolerant (Fig. 6  A) . In contrast, lymph node T cells from thymectomized, SEB-tolerized V/~8 TCR transgenic MRL, lpr/Ipr mice remained tolerant to SEB. This can also be seen by plotting the ratio of the proliferative response of lymph node T cells from SEB-tolerized MRL-Ipr/Ipr mice compared with SEBtolerized MILL-+ / + mice for different concentrations of SEB (Fig. 6 B) . Lymph node T cells from sham-thymectomized and Ipr/Ipr mice were injected with SEB (100/~g, i.p.) at 8 wk of age. There was a marked weight loss and a 60% mortality in Ipr/lpr mice, but no effect in + / + mice (Fig. 7) . In contrast, untolerized V38 TCK transgenic + / + and lpr/Ipr mice had equivalent weight loss and no mortality after injection with SEB (100 #g, i.p.) at 8 wk of age, comparable to previously reported SEB-induced weight loss (9, 10).
Effect of SEB Tolerization on Thymocytes.
Discussion
T cell tolerance induction after SEB administration has previously been shown to involve both anergy induction and clonal deletion (11, 12) . The effects of T cell activation by SEB are seen within i wk of SEB administration and consist of a limited expansion followed by clonal deletion of 50% of T cells (11) . The remaining V~8 + T cells do not respond to SEB. Biweekly administration of SEB into MRL-Ipr/Ipr mice also resulted in decreased CD4-CDS-B220 + T cells and renal disease (13) . The present experiments indicate that induction of T cell anergy and clonal deletion does occur in autoimmunme lpr/Ipr mice, but is slightly less efficient than that observed in + / + mice. This result is consistent with previous reports that in the presence of the self-antigen, clonal deletion of self-reactive (Mls, MHC) T cells does occur in Ipr/Ipr mice (14) (15) (16) . We also previously demonstrated that in Db/HY TCK transgenic C57BL/6-1pr/l_pr male mice, there was a small but detectable difference in intrathymic clonal deletion of self-reactive T cells (6) .
Anergy induction with SEB is associated with the development of TCRdunCD4a~CD8 auu T cells in lymph node of V/~8 TCK transgenic MR.L + / + and MRL-lpr/Ipr mice. Cell size analysis indicates these are small, resting T cells. In TCR V~8 transgenic mice, downregulation of V~8 may occur in a unique manner. There is normal expression of TCKo~/~ and CD3 despite low levels of VBS, suggesting that there is simultaneous expression of endogenously rearranged TCK V~ regions, as well as the TCK V~8 transgene (Fig. 3 C) . The transgenic VB8 gene has been found to efficiently suppress Ipr defect has been found to be due to a mutation of the Fas antigen, which mediates apoptosis in the thymus (2) (3) (4) MILL-lpr/lpr mice do not have a significant defect in maintenance of peripheral tolerance in the absence of the thymus, as thymectomy of SEB-tolerized mice at 2 wk of age completely eliminated the loss of tolerance to SEB at 4 wk of age. The proposal that Fas mediates apoptosis of neglected thymocytes is consistent with our previous observation that a rearranged TCR gene inhibits lymphoproliferative disease by inhibiting production of CD4 + CD8 + TCR ~ T cells (5) . In nontransgenic mice expressing endogenously rearranged TCK genes, a large percentage of CD4 + CD8 + TCR a~ T cells are thymocytes that fail to properly rearrange or express the TCK, resulting in production of neglected thymocytes that undergo apoptosis in the thymus (18) . In lpr mice, the Fas defect in the apoptosis of neglected thymocytes might lead to escape of increased numbers of these unselected T cells to the periphery, resulting in lymphadenopathy and autoimmunity. We propose that a rearranged TCK transgene eliminates lymphoproliferation by decreasing production of neglected cells due to abnormal TCK rearrangement.
We cannot yet fully explain how a TCK transgene might inhibit a defective Fas-dependent pathway of thymocyte development, yet not eliminate autoimmune features of Ipr mice (5, 6) . Failure to eliminate autoantibody production could be due to the requirement that B cell development in Ipr/Ipr mice is also affected by the defected Fas-related apoptosis pathway, resulting in autoreactive B cells. This is consistent with the observation of an intrinsic B cell defect in Ipr/lpr mice (19) . A B cell abnormality, by itself, has been noted to result in autoantibodies, but not severe autoimmune disease (20) . In addition to B cell abnormalities, we find an increase in autoreactive T cells expressing the rearranged TCK transgene in the TCK transgenic lpr/Ipr mice (6). It is possible that the Fas antigen plays a role in negative selection and donal deletion of autoreactive T cells, as well as on neglected T cells. Alternatively, as described above, some of the T cells expressing the self-reactive TCK transgene might develop into neglected thymocytes requiring Fas-induced apoptosis. In both cases, TCK transgenic mice would produce abnormal, potentially autoreactive T cells, but at lower numbers compared with nontransgenic mice. This is supported by the data in Table 1 , in which the production ratio for II.-2 and IFN-3, in tolerized relative to untolerized mice is reduced in the presence of the TCK V~8 transgene. A third possibility is that some aspects of organ disease in lpr mice might be related to failed apoptosis of abnormal cells unrelated to immune defects. Fas is expressed in the heart, liver, and ovaries (4), and defective apoptosis of cells at nonlymphoid sites might lead to tissue damage associated with mononuclear cell infiltrate. This is exemplified by the observation that synovial hyper-proliferation in MRL.Ipr/lpr mice has been reported to precede T cell infiltration and might be related to an apoptosis defect of a synovial cell (21) .
SEB has previously been shown to induce rapid weight loss after in vivo administration in normal mice, which was initially proposed to be due to production of Ib2 (9) . The data presented in this paper indicate that after neonatal tolerance induction, SEB does not induce weight loss in TCR V~8 transgenic MILL-+ / + mice, but induces a greater than normal weight loss and 60% mortality in SEB neonatally tolerized TCK V~8 transgenic MILL-Ipr/Ipr mice. This SEB hyper-responsiveness in vivo is consistent with the in vitro tolerance studies in which after 5 wk of age, a greater than normal response of T cells from neonatally tolerized MRLlpr/Ipr mice to SEB was observed compared with untolerized mice. SEB has also been shown to induce TNF-ol, Ibl, and Ib6 production by blood mononuclear cells (22) . These cytokines have been found to be increased in lpr/Ipr mice (23, 24) , and release of cytokines in vivo could lead to an acute septic shock-like state, weight loss, and death.
